EE05106B1 - Fosforit sisaldavate etleendiamiini derivaatide kaltsiumikompleks - Google Patents

Fosforit sisaldavate etleendiamiini derivaatide kaltsiumikompleks

Info

Publication number
EE05106B1
EE05106B1 EEP200200090A EEP200200090A EE05106B1 EE 05106 B1 EE05106 B1 EE 05106B1 EE P200200090 A EEP200200090 A EE P200200090A EE P200200090 A EEP200200090 A EE P200200090A EE 05106 B1 EE05106 B1 EE 05106B1
Authority
EE
Estonia
Prior art keywords
kappa
calcium complex
leendiamine
phosphorus
derivatives
Prior art date
Application number
EEP200200090A
Other languages
English (en)
Estonian (et)
Inventor
Platzek Johannes
Niedballa Ulrich
Michl G�nter
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7922563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05106(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1999144893 external-priority patent/DE19944893C2/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200090A publication Critical patent/EE200200090A/xx
Publication of EE05106B1 publication Critical patent/EE05106B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/04Chelating agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
EEP200200090A 1999-09-09 2000-09-06 Fosforit sisaldavate etleendiamiini derivaatide kaltsiumikompleks EE05106B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999144893 DE19944893C2 (de) 1999-09-09 1999-09-09 Calcium-Komplex von [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-. kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6, .kappa.N9,.kappa.O11]1-oxidato(6-)]-, hexahydrogen, dessen Salze und diese Komplexe enthaltende pharmazeutische Mittel
PCT/EP2000/008694 WO2001018011A1 (en) 1999-09-09 2000-09-06 Calcium complex of phosphorus containing ethylenediamine derivatives

Publications (2)

Publication Number Publication Date
EE200200090A EE200200090A (et) 2003-04-15
EE05106B1 true EE05106B1 (et) 2008-12-15

Family

ID=7922563

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200090A EE05106B1 (et) 1999-09-09 2000-09-06 Fosforit sisaldavate etleendiamiini derivaatide kaltsiumikompleks

Country Status (30)

Country Link
EP (1) EP1210353B1 (ko)
JP (1) JP2003508537A (ko)
KR (1) KR100650090B1 (ko)
CN (1) CN100341883C (ko)
AT (1) ATE245159T1 (ko)
AU (1) AU783982B2 (ko)
BG (1) BG65280B1 (ko)
BR (1) BR0013871A (ko)
CA (1) CA2380766C (ko)
CZ (1) CZ2002834A3 (ko)
DE (2) DE19964224B4 (ko)
DK (1) DK1210353T3 (ko)
EE (1) EE05106B1 (ko)
ES (1) ES2202178T3 (ko)
HK (1) HK1050202A1 (ko)
HR (1) HRP20020302B1 (ko)
HU (1) HUP0202873A3 (ko)
IL (1) IL148563A (ko)
MX (1) MXPA02001583A (ko)
NO (1) NO20021167L (ko)
NZ (1) NZ517708A (ko)
PL (1) PL354749A1 (ko)
PT (1) PT1210353E (ko)
RS (1) RS50125B (ko)
RU (1) RU2247727C2 (ko)
SK (1) SK3242002A3 (ko)
TW (1) TWI263641B (ko)
UA (1) UA74165C2 (ko)
WO (1) WO2001018011A1 (ko)
ZA (1) ZA200202742B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201514188A (zh) 2013-03-13 2015-04-16 Lantheus Medical Imaging Inc 製備釓磷維塞三鈉單水合物之方法
JP2023507016A (ja) 2019-12-20 2023-02-20 ブラッコ・イメージング・ソシエタ・ペル・アチオニ Boptaカルシウム錯体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
TW319763B (ko) * 1995-02-01 1997-11-11 Epix Medical Inc
US5919967A (en) * 1997-04-11 1999-07-06 Epix Medical, Inc. Process for synthesizing phosphodiesters

Also Published As

Publication number Publication date
ATE245159T1 (de) 2003-08-15
NZ517708A (en) 2003-10-31
KR100650090B1 (ko) 2006-11-27
MXPA02001583A (es) 2004-04-05
RS50125B (sr) 2009-03-25
RU2247727C2 (ru) 2005-03-10
CA2380766A1 (en) 2001-03-15
NO20021167D0 (no) 2002-03-08
HK1050202A1 (en) 2003-06-13
EP1210353B1 (en) 2003-07-16
PL354749A1 (en) 2004-02-23
IL148563A (en) 2005-12-18
IL148563A0 (en) 2002-09-12
DK1210353T3 (da) 2003-10-27
YU16102A (sh) 2005-06-10
HUP0202873A2 (hu) 2002-12-28
CN100341883C (zh) 2007-10-10
ZA200202742B (en) 2003-09-23
UA74165C2 (uk) 2005-11-15
BG65280B1 (bg) 2007-11-30
CZ2002834A3 (cs) 2002-07-17
EP1210353A1 (en) 2002-06-05
ES2202178T3 (es) 2004-04-01
CA2380766C (en) 2008-11-25
DE19964224A1 (de) 2001-06-28
DE60003931T2 (de) 2004-05-27
KR20020025256A (ko) 2002-04-03
HRP20020302B1 (en) 2005-08-31
AU783982B2 (en) 2006-01-12
NO20021167L (no) 2002-03-08
CN1373765A (zh) 2002-10-09
PT1210353E (pt) 2003-11-28
WO2001018011A1 (en) 2001-03-15
HRP20020302A2 (en) 2004-02-29
BG106488A (en) 2002-10-31
HUP0202873A3 (en) 2003-12-29
EE200200090A (et) 2003-04-15
BR0013871A (pt) 2002-05-21
WO2001018011A9 (en) 2002-09-06
AU7774900A (en) 2001-04-10
TWI263641B (en) 2006-10-11
SK3242002A3 (en) 2002-10-08
DE19964224B4 (de) 2005-09-01
JP2003508537A (ja) 2003-03-04
DE60003931D1 (de) 2003-08-21

Similar Documents

Publication Publication Date Title
TNSN98203A1 (fr) Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
TR199801115T2 (xx) Kinazolin t�revleri.
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
HU9601846D0 (en) Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
TR199900674T2 (xx) Kinazolin t�revleri ve bunlar� i�eren farmas�tik bile�imler.
IL162214A (en) Pyridine derivatives and pharmaceutical compositions containing the same
CA2129288A1 (en) Phosphonooxymethyl Esters of Taxane Derivatives
TNSN99162A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97108A1 (fr) Analogues d'indazole nouveaux
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
IL154755A0 (en) Antitumor theraphy comprising distamycin derivatives
CZ20012134A3 (cs) Fosfolipidové komplexy
EE05106B1 (et) Fosforit sisaldavate etleendiamiini derivaatide kaltsiumikompleks
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
ATE263179T1 (de) Kohlenhydrate derivate und die enthaltende zusammensetzungen
AP2001002369A0 (en) Pharmaceutical complex.
TR200000753T2 (tr) Mukabil antifungal ajan için prodrog olarak tetrahidrofuran fosfat ve hidroksi esterleri.
UA40656C2 (uk) Засіб "феррофол" для лікування залізодефіцитної анемії
TNSN91040A1 (fr) Derives de benzofuranne

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090906